Patents Assigned to LifeScience AS
  • N-acetylneuraminic acid compositions and methods of use
    Patent number: 12685741
    Abstract: The present invention relates to the field of viral disorders, and in particular to the use of natural compounds to inhibit viruses and viral infection. Compositions comprising NANA are provided for treating or preventing viral infections, such as those causing the common cold.
    Type: Grant
    Filed: October 11, 2018
    Date of Patent: July 21, 2026
    Assignee: LifeScience AS
    Inventors: Jan Remmereit, Hogne Vik
  • Sialic acid compositions for the use of inhibiting and treating coronavirus infection
    Patent number: 12390481
    Abstract: The present invention relates to the use of compositions comprising sialic acid to inhibit or treat coronavirus infections, and in particular those caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).
    Type: Grant
    Filed: November 13, 2023
    Date of Patent: August 19, 2025
    Assignee: LifeScience AS
    Inventor: Jan Remmereit
  • Sialic acid compositions for the use of inhibiting and treating coronavirus infection
    Patent number: 11813271
    Abstract: The present invention relates to the use of compositions comprising sialic acid to inhibit or treat coronavirus infections, and in particular those caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: November 14, 2023
    Assignee: LifeScience AS
    Inventor: Jan Remmereit